Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics
{{output}}
RNA-targeting therapeutics have enormous potential to precisely target disease-causing RNAs, extending beyond the traditional limits of "druggability" for small molecules, antibodies, and protein-targeting cell therapies. However, one crucial limitation is t... ...